RETATRUTIDE – GLP-3 (RT) | 20MG | 30MG | 60MG

This high-purity synthetic peptide is a pioneering “triple agonist” (targeting GLP-1, GIP, and GCGR) designed for in vitro research. It is studied for its unique ability to simultaneously modulate insulin secretion, satiety signaling, and direct hepatic lipid metabolism within cell-based models.

• Available Quantities: 20mg | 30mg | 60mg

• Form: Lyophilized Powder

• Purity: ≥99% (HPLC Verified)

• Molecular Weight: ~4921.82 g/mol

• Mechanism: Triple agonism of GLP-1R, GIPR, and GCGR for synergistic metabolic signaling.

INTENDED USE:

This peptide is intended for in vitro research only by qualified professionals. It is not for human or veterinary use, and must not be used in food, drugs, diagnostics, or cosmetics.

DISCLAIMER:

This compound has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. All use must follow institutional and regulatory guidelines.

TERMS OF SALE:

By purchasing from Apexin Peptides, the buyer affirms they are a qualified researcher or institution. All sales are final. The purchaser assumes full responsibility for handling, use, and regulatory compliance.